The purpose of the study is to determine the clinical impact of cyanoacrylate tissue adhesive treatment for Gastric Varices performed by Indiana University EUS physicians.
Using an IRB approved database (IU IRB#1209009522; NCT02037659), data collected from the database will be evaluated to identify complications, risk of rebleeding, death within 1 year of treatment, varices eradication and need for re-intervention associated with cyanoacrylate tissue adhesive (Dermabond) treatment performed by Indiana University Endoscopic Ultrasound (EUS) physicians.
Study Type
OBSERVATIONAL
Enrollment
119
Subjects will have undergone treatment and been enrolled into the existing registry.
Indiana University
Indianapolis, Indiana, United States
Impact of EUS guided treatment of Gastric varices post procedure complications and adverse events
Retrospective data review to Determine post procedure complications and adverse events at 24h, between 2 and 7 days and between 8 and 30 days after the procedure. Additionally, tracking rebleeding after first and second EUS. Moreover, looking at eradication of GV rate on second endoscopy (considered eradicated if absent or if residual varices have no or minimal flow on doppler)eradication, and need for re-intervention following cyanoacrylate tissue adhesive treatment for Gastric Varices performed by IU EUS physicians.
Time frame: Complications reviewed at time of retrospective study. EUS-guided sclerotherapy done between November 2012 and December 2021
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.